Effects of ranolazine on exercise capacity, right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot study

Abstract. Ranolazine, a late inward sodium current and fatty acid oxidation inhibitor, may improve right ventricular (RV) function in pulmonary arterial hypertension (PAH); however, the safety and efficacy of ranolazine in humans with PAH is unknown. Therefore, we sought to (1) determine whether ran...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pulm Circ
Päätekijät: Khan, Sadiya S., Cuttica, Michael J., Beussink-Nelson, Lauren, Kozyleva, Anastasia, Sanchez, Cynthia, Mkrdichian, Hamorabi, Selvaraj, Senthil, Dematte, Jane E., Lee, Daniel C., Shah, Sanjiv J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: University of Chicago Press 2015
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556506/
https://ncbi.nlm.nih.gov/pubmed/26401256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/682427
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia